Netherlands· NL-2d1d2d183ccc
Hezkue 12,5 mg/dosis, suspensie voor oraal gebruik
A sildenafil product containing sildenafilcitraat, registered in Netherlands by Aspargo Labs Italia S.r.l. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Sildenafil is registered in 14 of 19 countries.
Countries holding a registration under ATC G04BE03 (sildenafil), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Sildenafil · ATC G04BE03
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of sildenafil costs, country by country.
Normalised to the WHO defined daily dose (50 mg), the median price runs from $0.13 in United States to $21.46 in Italy — a ×168 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Sildenafil · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- IT Italy$21.46
- CH Switzerland$13.08
- US United States$0.13 (acquisition cost)
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- SILDENAFILCITRAAT
- Manufacturer
- Aspargo Labs Italia S.r.l
- Country
- Netherlands (NL)
- ATC code
- G04BE03
- ATC class
- Sildenafil
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id127981
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
399 interactions on record for sildenafil.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sildenafil · interactions on record
399 records
- 11 severe
- 118 moderate
- 4 minor
- 145 info
Most severe, free to view
- KetoconazoleH02CA03severe
- ErythromycinJ01FA01severe
- ClarithromycinJ01FA09severe
- KetoconazoleJ02AB02severe
121 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under G04BE03
Sildenafil, as other registers publish it.
- CanadaACCEL-SILDENAFILACCEL PHARMA INC
- CanadaACCEL-SILDENAFILACCEL PHARMA INC
- CanadaACCEL-SILDENAFILACCEL PHARMA INC
- PolandActigraBiofarm Sp. z o.o.
- PolandActigra ForteBiofarm Sp. z o.o.
- CanadaAG-SILDENAFIL TABLETSANGITA PHARMA INC.
- CzechiaAMFIDOREgis Pharmaceuticals PLC, Budapešť
- CzechiaAMFIDOREgis Pharmaceuticals PLC, Budapešť
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a6a8201c-36b0-449e-9704-e7fa9b32d61e GET /v1/drugs/a6a8201c-36b0-449e-9704-e7fa9b32d61e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Suspensie voor oraal gebruik",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h127981_smpc.pdf",
"strength": null,
"atc_label": "Sildenafil",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127981",
"excipients": [
"ACESULFAAM KALIUM (E 950)",
"AMMONIUMGLYCYRRHIZAAT",
"CITROENZUUR 0-WATER (E 330)",
"ESTRAGOL",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"MALTODEXTRINE",
"MALTODEXTRINE",
"MASKEERSMAAKSTOF",
"MAÏSZETMEEL, GEMODIFICEERD",
"MENTHOFURAN",
"NATRIUMBENZOAAT (E 211)",
"PEPERMUNTSMAAKSTOF",
"PULEGON",
"SUCRALOSE (E 955)",
"SUCRALOSE (E 955)",
"WATER, GEZUIVERD",
"XANTHAANGOM (E 415)"
],
"substances": [
"SILDENAFILCITRAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127981.pdf",
"authorised_at": "2022/08/29",
"procedure_number": "DE/H/7062/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "127981",
"additional_monitoring": "N"
}See everything about sildenafil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.